title: Osteonecrosis of the jaw in a patient with advanced non-small-cell lung cancer receiving bevacizumab.
authors.forename: Stamatis
authors.initials: S
authors.lastname: Katsenos
authors.forename: Charalampos
authors.initials: C
authors.lastname: Christophylakis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Psathakis
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000209:etiology*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab